All news

Rapport raises $410.7 million, Flowco lifts buyback to $200 million as Xcel plans $2 billion convertible

EverHint · · AI-summarised by FinFlash

A Monday deal roundup listed several smaller corporate moves. Rapport Therapeutics raised $410.7 million and Flowco increased its buyback to $200 million. Xcel Energy plans $2 billion of convertible senior notes due 2027, with a $300 million option, to repay short-term borrowings. Kewaunee is buying Nycom for $55 million, Colony Bankcorp completed its First Reliance merger, and the Axcelis-Veeco closing slipped to the first quarter of 2027.

So What?

Utility and biotech issuance shows equity-linked markets remain open despite the AI selloff. The Axcelis-Veeco delay is one to watch for chip-equipment investors.

Read original source

VECO company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.